Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) within Human Retinoic Acid Receptor gamma aa 1-100 (N terminal). The exact sequence is proprietary.
Database link: P13631-2
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents
This product is a recombinant rabbit monoclonal antibody.
Our Abpromise guarantee covers the use of ab187159 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
WB | 1/1000 - 1/2000. Detects a band of approximately 50 kDa (predicted molecular weight: 50 kDa). | |
ICC/IF | 1/100 - 1/250. |
Immunofluorescent analysis of HeLa cells labeling Retinoic Acid Receptor gamma with ab187159 at 1/250 and DAPI staining (blue).
ab187159 has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"